Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Morbidity
研究概览
简要总结
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.
详细描述
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization would also calculated 3 months after discharge.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •90 chronic cardiac failure patients in our hospital were selected and divided into two groups.
排除标准
- •Vavular diseases
研究组 & 干预措施
idiopathic dilated cardiomyopathy group
idiopathic dilated cardiomyopathy group treated with HTEA
干预措施: HTEA (Drug)
post-myocardial infarction group
post-myocardial infarction group treated with TEA
干预措施: HTEA (Drug)
结局指标
主要结局
Morbidity
时间窗: 1 months to 3 months after discharge
次要结局
- The decreased degree of NT-proBNP higher than 30%(3 months after discharge)
研究者
Wei Liu
Prof. Liu
Harbin Medical University